The Fas/FasL pathway can be a basis for exploring the intrinsic relationship and possible mechanism between T cell senescence and lung cancer, and provide the experimental basis and scientific strategy for immunotherapy of lung cancer in the elderly. The gene discussed is FAS; the disease is lung carcinoma.